CO2019011592A2 - Proceso para la fabricación de la forma alfa de vortioxetina hbr - Google Patents

Proceso para la fabricación de la forma alfa de vortioxetina hbr

Info

Publication number
CO2019011592A2
CO2019011592A2 CO2019011592A CO2019011592A CO2019011592A2 CO 2019011592 A2 CO2019011592 A2 CO 2019011592A2 CO 2019011592 A CO2019011592 A CO 2019011592A CO 2019011592 A CO2019011592 A CO 2019011592A CO 2019011592 A2 CO2019011592 A2 CO 2019011592A2
Authority
CO
Colombia
Prior art keywords
manufacture
alpha form
vortioxetine hbr
vortioxetine
hbr
Prior art date
Application number
CO2019011592A
Other languages
English (en)
Inventor
Hans Petersen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62111030&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO2019011592(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of CO2019011592A2 publication Critical patent/CO2019011592A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

RESUMEN Se proporciona un proceso para la fabricación de la forma α de vortioxetina HBr.
CO2019011592A 2017-04-25 2019-10-18 Proceso para la fabricación de la forma alfa de vortioxetina hbr CO2019011592A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201700264 2017-04-25
PCT/EP2018/060192 WO2018197360A1 (en) 2017-04-25 2018-04-20 Process for the manufacture of vortioxetine hbr alpha-form

Publications (1)

Publication Number Publication Date
CO2019011592A2 true CO2019011592A2 (es) 2019-10-31

Family

ID=62111030

Family Applications (1)

Application Number Title Priority Date Filing Date
CO2019011592A CO2019011592A2 (es) 2017-04-25 2019-10-18 Proceso para la fabricación de la forma alfa de vortioxetina hbr

Country Status (26)

Country Link
US (1) US11124491B2 (es)
EP (1) EP3615518B1 (es)
JP (1) JP7121751B2 (es)
KR (1) KR102551433B1 (es)
CN (1) CN110520415A (es)
AU (1) AU2018258947C1 (es)
BR (1) BR112018076411A2 (es)
CA (1) CA3059515A1 (es)
CL (1) CL2019003024A1 (es)
CO (1) CO2019011592A2 (es)
CY (1) CY1124974T1 (es)
DK (1) DK3615518T3 (es)
ES (1) ES2905962T3 (es)
HR (1) HRP20220108T1 (es)
HU (1) HUE057993T2 (es)
IL (1) IL270052B2 (es)
LT (1) LT3615518T (es)
MA (1) MA49056A (es)
MX (1) MX2019012765A (es)
PL (1) PL3615518T3 (es)
PT (1) PT3615518T (es)
RS (1) RS62823B1 (es)
SG (1) SG11201909678PA (es)
SI (1) SI3615518T1 (es)
WO (1) WO2018197360A1 (es)
ZA (1) ZA201906829B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210087155A1 (en) * 2018-02-06 2021-03-25 Piramal Enterprises Limited An improved process for the preparation of vortioxetine and salts thereof
CN112125868B (zh) * 2020-09-25 2021-08-03 中山万远新药研发有限公司 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
MX2008016141A (es) * 2006-06-16 2009-02-04 Lundbeck & Co As H 1-[2-(2,4-dimetilfenilsulfanil)-fenil] piperazina como un compuesto con actividad combinada de recaptación de serotonina, 5-ht3 y 5-ht1a.para el tratamiento de daño cognitivo.
TW200848411A (en) * 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
EP2897943B1 (en) 2012-09-19 2019-04-24 Sandoz AG Crystalline form of vortioxetine hydrobromide
WO2015114395A1 (en) * 2014-01-31 2015-08-06 Egis Gyógyszergyár Zrt. Process for the preparation of vortioxetine salts
US9687484B2 (en) 2014-07-18 2017-06-27 Dipharma Francis S.R.L. Crystalline forms of an antidepressant compound
CN105367515B (zh) 2015-05-08 2017-10-27 北京北陆药业股份有限公司 一种氢溴酸沃替西汀α晶型的制备方法
CN104910099B (zh) 2015-05-22 2017-03-08 扬子江药业集团有限公司 一种氢溴酸沃替西汀晶体的制备方法
CN106316986B (zh) 2015-07-03 2019-02-05 成都弘达药业有限公司 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪氢溴酸盐α型晶体的制备方法

Also Published As

Publication number Publication date
BR112018076411A2 (pt) 2019-04-09
KR20190141155A (ko) 2019-12-23
KR102551433B1 (ko) 2023-07-04
RU2019133770A (ru) 2021-05-25
PT3615518T (pt) 2022-02-14
CA3059515A1 (en) 2018-11-01
IL270052A (es) 2019-12-31
AU2018258947A1 (en) 2019-10-31
DK3615518T3 (da) 2022-02-07
IL270052B1 (en) 2023-08-01
AU2018258947B2 (en) 2021-02-25
US20200165217A1 (en) 2020-05-28
MX2019012765A (es) 2019-12-05
AU2018258947C1 (en) 2021-08-26
CY1124974T1 (el) 2023-01-05
CL2019003024A1 (es) 2020-02-21
CN110520415A (zh) 2019-11-29
WO2018197360A1 (en) 2018-11-01
EP3615518A1 (en) 2020-03-04
US11124491B2 (en) 2021-09-21
EP3615518B1 (en) 2021-12-15
HRP20220108T1 (hr) 2022-04-15
HUE057993T2 (hu) 2022-06-28
MA49056A (fr) 2020-03-04
PL3615518T3 (pl) 2022-03-07
LT3615518T (lt) 2022-03-10
SI3615518T1 (sl) 2022-02-28
JP7121751B2 (ja) 2022-08-18
RS62823B1 (sr) 2022-02-28
ES2905962T3 (es) 2022-04-12
SG11201909678PA (en) 2019-11-28
RU2019133770A3 (es) 2021-08-27
JP2020517674A (ja) 2020-06-18
IL270052B2 (en) 2023-12-01
ZA201906829B (en) 2022-03-30

Similar Documents

Publication Publication Date Title
TWD187539S (zh) 鞋之部分
TWD187540S (zh) 鞋之部分
MX2016014192A (es) Procesos para preparar un inhibidor de cinasas de janus 1 (jak1) y nuevas formas de este.
PE20171094A1 (es) Anticuerpos anti-cd38 para el tratamiento de la leucemia linfoblastica aguda
GR20140100479A (el) Συνθεση λιραγλουτιδης
CY1121602T1 (el) Συνθεση της κοπανλισιμπης και του διυδροχλωρικου αλατος της
TWD175313S (zh) 相機模組之部分
CL2020003254A1 (es) Procedimiento para la deshidratación de agua fangosa acuosa
CL2018002756A1 (es) Un proceso mejorado para la preparación de tartrato de butorfanol.
ECSDI17024111S (es) Recipiente
CO2019011592A2 (es) Proceso para la fabricación de la forma alfa de vortioxetina hbr
TWD192085S (zh) 胸罩
CL2017000645A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
EA201491913A1 (ru) Синтез калебина-а и его биологически активных аналогов
ITBA20140018A1 (it) Macchinario per la produzione di stracciatella
CL2021000902A1 (es) Método para la fabricación de gemas sintéticas.
IT201800011142A1 (it) Forma per la produzione di calzature
TWD188654S (zh) 巴士
TWD180363S (zh) 水龍頭
BR112017000697A2 (pt) “processo para a produção de compostos de biaril”
IT201600127907A1 (it) Mescola per la produzione di suole per calzature
CL2017001466A1 (es) Un proceso para la fabricación de idalopirdina
DOP2017000001A (es) Forma polimórfica novedosa del clorhidrato de n-[2-(6-fluoro-1h-indol-3-il)etil]-3-(2,2,3,3-tetrafluoropropoxi)bencilamina para el tratamiento del alzhéimer
ES1232899Y (es) Calzado femenino
TWD170031S (zh) 鞋面的部分（二）